Contract 75N91018D00006
Idaho Hospital Association Inc · Department Of Health And Human Services · May 1, 2018
Idaho Hospital Association Inc was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on May 1, 2018 for an undisclosed amount of work in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology). It was awarded under full and open competition. The contract has been modified 5 times since the base award It uses order dependent (idv allows pricing arrangement to be determined separately for each order) contract pricing. The most recent modification was on July 7, 2023. If all options are exercised, the contract could reach $500.00 million.
Contract details
- PIID
- 75N91018D00006
- Award type
- —
- Pricing
- Order Dependent (Idv Allows Pricing Arrangement To Be Determined Separately For Each Order)
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- First action
- May 1, 2018
- Latest action
- July 7, 2023
Description
SURVEILLANCE,EPIDEMIOLOGY AND END RESULTS (SEER)
Modification timeline
-
July 7, 2023Mod P00005$0
-
March 16, 2023Mod P00004$0
-
August 26, 2022Mod P00003SURVEILLANCE,EPIDEMIOLOGY AND END RESULTS (SEER) - IDAHO HOSPITAL ASSOC. (CANCER SURVEILLANCE)$0
-
November 16, 2021Mod P00002EO14042- SURVEILLANCE,EPIDEMIOLOGY AND END RESULTS (SEER) - IDAHO HOSPITAL ASSOC. (CANCER SURVEILLANCE)$0
-
September 27, 2019Mod P00001SURVEILLANCE,EPIDEMIOLOGY AND END RESULTS (SEER) 05/01/2018-4/30/2028$0
-
May 1, 2018Base awardIGF::OT::IGF SURVEILLANCE,EPIDEMIOLOGY AND END RESULTS (SEER) PROGRAM$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| The Emmes Company, Llc | Department Of Health And Human Services | April 1, 2026 | $771.5K |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $8.00M |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $9.22M |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $327.13M |
| The Brain Donor Project, Inc | Department Of Health And Human Services | April 1, 2026 | $1.27M |
| Leidos Biomedical Research Inc | Department Of Health And Human Services | April 1, 2026 | $20.43M |
Top contractors in NAICS 541715
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Fluor Marine Propulsion, Llc | 2 | $28.31B |
| 2 | California Institute Of Technology | 818 | $19.55B |
| 3 | Lockheed Martin Corp | 28 | $9.64B |
| 4 | The Aerospace Corporation | 393 | $8.97B |
| 5 | Lockheed Martin Corp | 23 | $7.69B |
| 6 | The Johns Hopkins University Applied Physics Laboratory Llc | 1,336 | $7.27B |
| 7 | Leidos Biomedical Research Inc | 167 | $6.23B |
| 8 | The Mitre Corporation | 398 | $6.07B |
| 9 | Lockheed Martin Corporation | 15 | $5.04B |
| 10 | Booz Allen Hamilton Inc | 169 | $4.28B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N91018D00006?
Contract 75N91018D00006 is a federal contract awarded to Idaho Hospital Association Inc by Department Of Health And Human Services on May 1, 2018 for an undisclosed amount of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). It has been modified 5 times since the base award.
Who won contract 75N91018D00006?
Idaho Hospital Association Inc won contract 75N91018D00006 from Department Of Health And Human Services.
How much is contract 75N91018D00006 worth?
Contract 75N91018D00006 has obligated $0 to date but carries a potential ceiling of $500.00 million if fully funded and all options are exercised.